Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) : Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening
Acknowledging the increasing number of studies describing the use of whole-body MRI for cancer screening, and the increasing number of examinations being performed in patients with known cancers, an international multidisciplinary expert panel of radiologists and a geneticist with subject-specific expertise formulated technical acquisition standards, interpretation criteria, and limitations of whole-body MRI for cancer screening in individuals at higher risk, including those with cancer predisposition syndromes. The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) proposes a standard protocol for individuals at higher risk, including those with cancer predisposition syndromes. ONCO-RADS emphasizes structured reporting and five assessment categories for the classification of whole-body MRI findings. The ONCO-RADS guidelines are designed to promote standardization and limit variations in the acquisition, interpretation, and reporting of whole-body MRI scans for cancer screening. Published under a CC BY 4.0 license Online supplemental material is available for this article.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:299 |
---|---|
Enthalten in: |
Radiology - 299(2021), 3 vom: 01. Juni, Seite 494-507 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Petralia, Giuseppe [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 05.08.2021 Date Revised 05.08.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1148/radiol.2021201740 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM324582277 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM324582277 | ||
003 | DE-627 | ||
005 | 20231225190625.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1148/radiol.2021201740 |2 doi | |
028 | 5 | 2 | |a pubmed24n1081.xml |
035 | |a (DE-627)NLM324582277 | ||
035 | |a (NLM)33904776 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Petralia, Giuseppe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) |b Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.08.2021 | ||
500 | |a Date Revised 05.08.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Acknowledging the increasing number of studies describing the use of whole-body MRI for cancer screening, and the increasing number of examinations being performed in patients with known cancers, an international multidisciplinary expert panel of radiologists and a geneticist with subject-specific expertise formulated technical acquisition standards, interpretation criteria, and limitations of whole-body MRI for cancer screening in individuals at higher risk, including those with cancer predisposition syndromes. The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) proposes a standard protocol for individuals at higher risk, including those with cancer predisposition syndromes. ONCO-RADS emphasizes structured reporting and five assessment categories for the classification of whole-body MRI findings. The ONCO-RADS guidelines are designed to promote standardization and limit variations in the acquisition, interpretation, and reporting of whole-body MRI scans for cancer screening. Published under a CC BY 4.0 license Online supplemental material is available for this article | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Video-Audio Media | |
700 | 1 | |a Koh, Dow-Mu |e verfasserin |4 aut | |
700 | 1 | |a Attariwala, Raj |e verfasserin |4 aut | |
700 | 1 | |a Busch, Joseph J |e verfasserin |4 aut | |
700 | 1 | |a Eeles, Ros |e verfasserin |4 aut | |
700 | 1 | |a Karow, David |e verfasserin |4 aut | |
700 | 1 | |a Lo, Gladys G |e verfasserin |4 aut | |
700 | 1 | |a Messiou, Christina |e verfasserin |4 aut | |
700 | 1 | |a Sala, Evis |e verfasserin |4 aut | |
700 | 1 | |a Vargas, Hebert A |e verfasserin |4 aut | |
700 | 1 | |a Zugni, Fabio |e verfasserin |4 aut | |
700 | 1 | |a Padhani, Anwar R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Radiology |d 1945 |g 299(2021), 3 vom: 01. Juni, Seite 494-507 |w (DE-627)NLM000054860 |x 1527-1315 |7 nnns |
773 | 1 | 8 | |g volume:299 |g year:2021 |g number:3 |g day:01 |g month:06 |g pages:494-507 |
856 | 4 | 0 | |u http://dx.doi.org/10.1148/radiol.2021201740 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 299 |j 2021 |e 3 |b 01 |c 06 |h 494-507 |